Acediasulfone

Acediasulfone (INN) is an antimicrobial drug, which also has antimalarial activity. It is a long-acting prodrug of dapsone, which is used for treating leprosy.

Acediasulfone
Clinical data
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.001.131
Chemical and physical data
FormulaC14H14N2O4S
Molar mass306.34 g·mol−1
3D model (JSmol)
  (verify)

Synthesis

Dapsone is somewhat inconvient to administer to patients because of its rather low water solubility.

Acediasulfone synthesis:[1] CH 254803 and CH 278482 (1949, 1952, to Cilag Ltd.); Rawlins, U.S. Patent 2,589,211 (1952 to Parke-Davis).

In the search for more easily administered drugs, 1 was reacted with bromoacetic acid to give acediasulfone (3) which can be administered as a water-soluble salt.

References

  1. Jackson EL (February 1948). "Certain N-alkyl, N-carboxyalkyl and N-hydroxyalkyl derivatives of 4,4'-diaminodiphenyl sulfone". Journal of the American Chemical Society. 70 (2): 680–4. doi:10.1021/ja01182a074. PMID 18907772.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.